Cardiology has advanced with three-dimensional echocardiography (3DE), offering real-time visualization of cardiac structures. Surpassing 2D imaging, 3DE improves diagnostic accuracy, enhances procedural planning, and guides interventions. With advancements in artificial intelligence, augmented/virtual reality, and machine learning, 3DE will continue transforming cardiovascular care, shaping the future of diagnosis and treatment.
In the last decade, cardiovascular imaging has advanced significantly, with 3D echocardiography leading a transformation in diagnostic and interventional capabilities. Unlike traditional 2D imaging, 3D echocardiography provides detailed, real-time visualization of heart structures, including complex valves and chambers, in multiple planes, which has improved diagnostic precision and procedural planning. This modality allows clinicians to assess structures like the mitral and tricuspid valves more comprehensively, aiding in precise measurements and the detection of morphological abnormalities that are challenging to visualize in 2D. Additionally, 3D echocardiography has become indispensable in guiding structural heart interventions, such as valve repairs and transcatheter procedures, by offering live feedback and spatial orientation. Overall, these advancements have reshaped cardiovascular care, enabling more accurate diagnoses, better outcomes in minimally invasive procedures, and a shift toward image-guided precision in treatment planning.
2. In what ways does 3D echocardiography improve the accuracy of diagnosis and spatial visualization when compared to traditional 2D echocardiography? What key limitations does it address?
3D echocardiography enables sophisticated measurements, offering a more comprehensive evaluation of cardiac anatomy and enhancing the overall diagnostic workflow. It addresses challenges such as limited visualization of complex valve geometries, difficulty in determining chamber volumes, and reduced spatial awareness, making it vital for accurate diagnoses and guiding minimally invasive interventions. Furthermore, 3D echocardiography provides a level of detail that goes beyond what is achievable with traditional surgical views. By utilizing cropping techniques, clinicians can isolate specific areas of interest and remove surrounding structures, allowing for clearer visualization. For instance, when examining the tricuspid valve (TV), the interatrial septal wall can be cropped away in seconds, providing a real-time, dynamic view of the tricuspid valve throughout the cardiac cycle. This ability to focus on and directly observe structures in 3D offers a significant advantage over traditional 2D imaging.
When pathology is visualized in detail, it allows for more precise solutions, enabling us to select the most appropriate devices for the right candidates. For example, in percutaneous paravalvular leak closure, accurate measurement of defects is critical—just a 2mm discrepancy can lead to life-threatening complications. Without 3D echocardiography, patients may be referred for cardiac surgery rather than considered for a percutaneous procedure. The ability to visualize and measure defects in detail with 3D imaging significantly enhances the treatment approach, reducing unnecessary surgery referrals and allowing for more precise and effective percutaneous interventions, which in turn results in better patient outcomes.
3D echocardiography plays a vital role in guiding transcatheter procedures by providing detailed, real-time visualization of cardiac anatomy, allowing clinicians to assess complex structures like valves and congenital or acquired defects with exceptional clarity. This advanced imaging technique is essential for both procedural guidance and preprocedural patient and device selection, ensuring that the most suitable approach is chosen based on precise anatomical and functional assessments. Its integration into interventional cardiology has significantly increased procedural success rates while reducing reliance on fluoroscopy, minimizing complications, and enhancing patient safety. Ultimately, this has transformed the outcomes of transcatheter procedures, leading to more effective interventions and better overall patient care; additionally, certain procedures, such as paravalvular leak closure and MitraClip /TriClip placements, should not be performed without 3D echocardiography due to the critical insights it provides.
One of the most transformative developments in 3D echocardiography is the integration of artificial intelligence (AI), which aids in automating measurements, detecting abnormalities, and enhancing image quality. This has been further enhanced by automated post-processing software powered by AI, accelerating image reconstruction and allowing for immediate visualization and analysis. Additionally, high-frequency transducers and advanced signal processing technologies have significantly improved image clarity, providing more detailed and accurate anatomical information. The fusion of 3D echocardiography with other imaging modalities like CT and MRI offers a comprehensive, multi-dimensional view of the heart, enhancing diagnostic precision. Together, these innovations have made 3D echocardiography more accurate, efficient, and clinically applicable, making it an essential tool for guiding complex cardiac interventions.
The integration of artificial intelligence (AI) and machine learning (ML) is poised to significantly transform the future of 3D echocardiography, particularly in image analysis and diagnostic accuracy. AI and ML algorithms can automate the interpretation of complex 3D images, reducing the time required for analysis and minimizing human error. These technologies can enhance image quality through noise reduction and improved resolution, allowing for clearer visualization of cardiac structures. Additionally, AI-driven tools can identify patterns and anomalies that may be overlooked by the human eye, leading to earlier and more accurate diagnoses. By facilitating advanced predictive analytics, AI and ML can assist clinicians in risk stratification and treatment planning, ultimately improving patient outcomes and streamlining clinical workflows. As these technologies continue to evolve, they will likely play an integral role in refining the accuracy and efficiency of 3D echocardiography in everyday clinical practice.
Augmented reality (AR) and virtual reality (VR) are rapidly emerging as powerful tools to enhance physician training and procedure planning in cardiology. These immersive technologies facilitate interactive exploration of 3D cardiac models, allowing trainees to practice interpreting echocardiographic images and diagnosing conditions in a risk-free, controlled environment. By providing a realistic, dynamic view of the heart’s anatomy—rather than static, simplified lines—AR and VR technologies help clinicians develop a more surgical, hands-on approach. For procedure planning, AR can overlay 3D echocardiographic data onto the surgeon’s real-time view, improving spatial awareness and supporting more informed decision-making. As AR and VR technologies continue to evolve, they are set to revolutionize both education and clinical practice, particularly in the realm of 3D echocardiography.
Previously, directly imaging the pulmonary valve was challenging, and our understanding of the tricuspid valve anatomy was limited until the development of 3D echocardiography. Now, with enhanced knowledge of cardiac anatomy and pathophysiology, we’re able to address these complexities through advanced percutaneous procedures.
For example, in pulmonary valve stenosis, we once relied solely on gradient-based classification, which could be influenced by factors such as pregnancy or left-to-right shunts, potentially skewing the assessment of stenosis severity. With 3D echocardiography, however, we can measure valve area directly, providing a more accurate evaluation.
In oncology patients undergoing chemotherapy, 3D-derived ejection fraction (EF) is significantly more sensitive than traditional 2D measurements, allowing us to detect early signs of cardiotoxicity before they become clinically problematic. Beyond these, there are countless other applications where 3D imaging enables superior diagnostic accuracy and procedural guidance, fundamentally advancing patient care.
The biggest challenge in adopting 3D echocardiography is overcoming preconceived notions. Many doctors still believe that 2D echocardiography is sufficient, so despite having access to 3D technology in many centers, it remains underutilized in daily practice. There are also limited training opportunities in this field. As the Global Society of Cardiology, we regularly organize national and international 3D echocardiography courses to address this gap.
Another hurdle is the misconception that 3D echocardiography is time-consuming. Busy doctors and echocardiographers, focused on their routine workload, may hesitate to integrate it. However, once incorporated into daily practice, 3D echocardiography actually saves time by providing a more complete and precise assessment. Without 3D, an echocardiographic evaluation is truly incomplete.
In the past, we classified tricuspid regurgitation without fully understanding the underlying pathophysiology or detailed valve anatomy. This often led to a "watch and wait" approach. Today, however, we can describe tricuspid valve structure and function in much greater detail, revealing that each tricuspid valve is unique—almost like a fingerprint. This deeper understanding allows us to offer more targeted and appropriate treatment options, such as TriClip and Vdyne, as well as other advanced therapies like Forma repair and valve replacement. These options enable us to provide individualized care that better addresses the specific needs of each patient.
In heart failure management, 3D echocardiography plays a critical role in evaluating not only left ventricular volume and geometry but also the assessment of the right ventricle, both of which are key factors in determining prognosis. This advanced imaging technique allows for a comprehensive evaluation of wall motion abnormalities and provides accurate measurements of ejection fraction, aiding in the classification of heart failure severity. Additionally, by identifying specific morphological changes—such as left ventricular hypertrophy or dilatation—clinicians can tailor therapeutic strategies. This includes optimizing medical management and planning for advanced interventions like left ventricular assist devices (LVADs) or heart transplantation. Ultimately, 3D echocardiography enhances the precision of assessments, leading to more individualized treatment approaches and improved patient outcomes.
For congenital heart diseases, 3D echocardiography provides intricate details of cardiac anatomy, allowing for accurate visualization of structural defects such as ventricular septal defects, atrial septal defects, and anomalous pulmonary venous return. This enhanced imaging capability enables cardiologists to assess the severity and location of defects, which is essential for planning interventions like catheter-based repairs or surgical corrections.
Moreover, 3D echocardiography facilitates better communication among multidisciplinary teams involved in patient care, allowing for more effective pre-procedural planning and decision-making. By providing a comprehensive view of the cardiac structure, it enhances the overall management of complex cases, improving outcomes and patient safety.
Many hospitals already have 3D echocardiography equipment, but its full integration into daily practice remains limited. When fully adopted, 3D echocardiography can reduce procedural time by providing more accurate and comprehensive imaging, allowing for better planning and faster execution of interventions. This leads to fewer complications, shorter recovery times, and improved patient throughput. The technology helps streamline procedures, reduce the need for follow-up tests, and ultimately lowers healthcare costs, making it a valuable tool for hospitals that already have 3D echocardiography equipment.
The metaverse allows for immersive, virtual environments where specialists from around the world can meet, collaborate, and analyze patient data in real-time. With 3D echocardiography, clinicians can share interactive, high-resolution images and models of the heart, allowing for more precise discussions, case reviews, and joint decision-making. This virtual collaboration enhances the accessibility of expert opinions, reduces geographical barriers, and improves the efficiency of multidisciplinary teams. Additionally, the metaverse can facilitate virtual training and educational opportunities, allowing healthcare professionals to practice techniques or explore complex cases in a risk-free, simulated environment.
As the Global Society of Cardiology, we organized the first cardiology congress in the metaverse in 2023 with great success and hosted the first case competition this year, further highlighting the potential of this technology to foster innovation, knowledge sharing, and global collaboration in cardiovascular care.
The next wave of technological innovations in 3D echocardiography is likely to focus on enhanced image resolution, real-time data integration, and the combination of augmented reality (AR) with 3D imaging, as well as touchless cropping through gesture control, along with artificial intelligence (AI) to further improve diagnostic accuracy and procedural planning. AI algorithms may assist in automating measurements, detecting subtle abnormalities, and predicting patient outcomes with greater precision, thus reducing human error and streamlining workflows. Additionally, advancements in portable and wearable 3D echocardiography devices could increase accessibility, allowing for on-the-spot diagnostics in various healthcare settings, including remote areas. These developments will not only enhance early detection and risk stratification but also enable more personalized treatment plans, such as tailoring device implantation and interventions to individual anatomical and pathological characteristics. Overall, these innovations will revolutionize both the diagnostic and therapeutic aspects of cardiology by improving patient outcomes, reducing healthcare costs, and increasing efficiency in clinical practice.
Dr. Tugba Kemaloglu Oz is the President of the Global Society of Cardiology and is globally renowned for her leadership in advancing cardiovascular education and fostering innovation. An esteemed Associate Professor of Cardiology, she is internationally recognized for her expertise in 3D and transesophageal echocardiography. Dr. Kemaloglu Oz serves as a cardiology consultant at Alice Springs Hospital and Flinders University in Australia. She is a prolific author and an editorial board member for leading journals, actively organizes international imaging courses, and advocates for the empowerment of women in cardiology.
